1. 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. (9th November 2020) Authors: Marron, Thomas; Kodysh, Julia; Rubinsteyn, Alex; Finnigan, John; Blazquez, Ana; Saxena, Mansi; Meseck, Marcia; O'Donnell, Timothy; Delbeau, Daniela; Galsky, Matthew; Doroshow, Deborah; Miles, Brett; Misiukiewicz, Krysztof; Irie, Hanna; Tiersten, Amy; Parekh, Samir; Posner, Marshall; Wolf, Andrea;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. (9th November 2020) Authors: Marron, Thomas; Kodysh, Julia; Rubinsteyn, Alex; Finnigan, John; Blazquez, Ana; Saxena, Mansi; Meseck, Marcia; O'Donnell, Timothy; Delbeau, Daniela; Galsky, Matthew; Doroshow, Deborah; Miles, Brett; Misiukiewicz, Krysztof; Irie, Hanna; Tiersten, Amy; Parekh, Samir; Posner, Marshall; Wolf, Andrea;... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 90 Potentiation of T-cell mediated tumor killing via modulation of the fas/fasL pathway. (9th November 2020) Authors: Boiarsky, Jonathan; Upadhyay, Ranjan; Svensson-Arvelund, Judit; Wroblewska, Aleksandra; Bhalla, Sherry; Scholler, Nathalie; Bot, Adrian; Rossi, John; Parekh, Samir; Sadek, Norah; Baccarini, Alessia; Merad, Miriam; Brown, Brian; Brody, Joshua Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 90 Potentiation of T-cell mediated tumor killing via modulation of the fas/fasL pathway. (9th November 2020) Authors: Boiarsky, Jonathan; Upadhyay, Ranjan; Svensson-Arvelund, Judit; Wroblewska, Aleksandra; Bhalla, Sherry; Scholler, Nathalie; Bot, Adrian; Rossi, John; Parekh, Samir; Sadek, Norah; Baccarini, Alessia; Merad, Miriam; Brown, Brian; Brody, Joshua Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed/refractory multiple myeloma. Issue 1 (2nd January 2021) Authors: Richard, Shambavi; Jagannath, Sundar; Cho, Hearn Jay; Parekh, Samir; Madduri, Deepu; Richter, Joshua; Chari, Ajai Journal: Expert review of hematology Issue: Volume 14:Issue 1(2021) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma. Issue 9 (28th July 2020) Authors: Van Oekelen, Oliver; Parekh, Samir; Cho, Hearn J.; Vishnuvardhan, Nivetha; Madduri, Deepu; Richter, Joshua; Ip, Chun; Lau, Kenneth; Florendo, Erika; Mancia, Ines S.; Thomas, Joanne; Verina, Daniel; Chan, Elaine; Zarychta, Katarzyna; La, Lisa; Strumolo, Gina; Melnekoff, David T.; Leshchenko, Viole... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 9(2020) Page Start: 2208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma. (15th June 2022) Authors: Restrepo, Paula; Bhalla, Sherry; Ghodke-Puranik, Yogita; Aleman, Adolfo; Leshchenko, Violetta; Melnekoff, David T.; Agte, Sarita; Jiang, Joy; Madduri, Deepu; Richter, Joshua; Richard, Shambavi; Chari, Ajai; Cho, Hearn Jay; Jagannath, Sundar; Walker, Christopher J.; Landesman, Yosef; Laganà, Aless... Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD). Issue 12 (15th October 2021) Authors: Kalff, Anna; Khong, Tiffany; Ramachandran, Malarmathy; Walker, Patricia; Schwarer, Anthony; Roberts, Andrew W.; Campbell, Philip; Filshie, Robin; Norton, Sam; Reynolds, John; Young, Mary; Pierceall, William; Thakurta, Anjan; Guo, Manman; Oppermann, Udo; Wang, Maria; Ren, Yan; Kennedy, Nola; Parek... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 2981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Issue 12 (December 2018) Authors: Dunleavy, Kieron; Fanale, Michelle A; Abramson, Jeremy S; Noy, Ariela; Caimi, Paolo Fabrizio; Pittaluga, Stefania; Parekh, Samir; Lacasce, Ann; Hayslip, John W; Jagadeesh, Deepa; Nagpal, Sunil; Lechowicz, Mary Jo; Gaur, Rakesh; Lucas, Andrea; Melani, Christopher; Roschewski, Mark; Steinberg, Seth... Journal: Lancet Issue: Volume 5:Issue 12(2018) Page Start: e609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HIV and Autoimmune Hepatitis: A Case Series and Literature Review: 2224. (October 2017) Authors: Spiritos, Zachary; Reynolds, Paul; Parekh, Samir; Perricone, Adam; Quigley, Brian Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗